Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
However, all integrase inhibitors were associated with similar weight gain.
Eight lessons from an HIV long-term survivor diagnosed in 1991 and determined to face fear and live life with hope in her heart.
Switching to an integrase inhibitors is not tied to gain in bad fat, according to recent study.
A recent study sheds light on weight gain after switching to new form of tenofovir.
Oriol R. Gutierrez Jr. discusses the challenges of weight gain while living with HIV with Lepena Reid and Liz Highleyman.
COVID-19, HIV vaccines, cure news and long-acting injectables stood out among the top HIV treatment stories of the year.
The antiretroviral drug class includes bictegravir, dolutegravir, elvitegravir and raltegravir.
A study looked at the fat composition of people who switched their antiretrovirals to include an integrase inhibitor.
This may reflect loss of the weight-suppressing effect of the older version of the drug.
Aging with HIV won’t slow down Robert Gillum.
Overweight and obesity are linked to a host of health problems.
Some HIV meds are linked to weight gain, but we don’t yet know why.
HIV advocate Lepena Reid confronts weight gain.
A healthy diet and exercise are key to controlling excess weight.
The reasons for gaining weight aren’t always clear.
More studies link dolutegravir and other drugs to weight gain among people with HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.